(NPD) is a Cluster B personality disorder defined in by a pervasive pattern of grandiosity, need for admiration, and lack of empathy, with onset by early adulthood and impairment across contexts. Two phenotypes dominate the clinical literature: the overt or grandiose presentation, more visible in social and occupational settings, and the covert or vulnerable presentation, marked by hypersensitivity, shame, and depressive features that often bring the patient to care. Patients rarely present asking for help with narcissism itself; they arrive with depression, suicidality after a narcissistic injury, substance use, or relational crisis, and the personality structure is identified only on careful longitudinal assessment. No medication is approved for NPD, and psychotherapy remains the foundation of treatment, with pharmacotherapy reserved for comorbid mood, anxiety, or impulsive aggression. The bottom line: NPD is under-recognized in routine practice, drives high comorbidity and suicide risk after status loss, and is treatable but slow to change.
NPD is uncommon in epidemiologic surveys but over-represented in clinical settings, with men diagnosed more often than women across most large studies.[1-2] Comorbidity, not narcissism per se, usually drives the clinical encounter.
Prevalence
- Lifetime community prevalence in the U.S. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) was approximately 6.2%, with substantial variation by methodology across surveys; many subsequent estimates cluster between 0% and 6%.[1-2]
- Twelve-month prevalence is lower than lifetime, and clinical prevalence (outpatient and inpatient psychiatric settings) is substantially higher than community figures.[2]
Demographics and course
- Men are diagnosed with NPD more often than women, with male-to-female ratios near 3:2 in NESARC and similar surveys.[1]
- Onset is by early adulthood; traits often emerge in adolescence but a diagnosis is reserved for persistent, pervasive patterns causing impairment.[3]
- Prevalence appears to decline with age in cross-sectional data, consistent with the broader trajectory of Cluster B traits.[1-2]
Comorbidity and risk factors
- High comorbidity with substance use disorders, major depressive disorder, , , and other personality disorders (especially borderline, histrionic, antisocial, and paranoid).[1-2]
- Lifetime suicide attempt rates are elevated, particularly after narcissistic injury (job loss, public humiliation, divorce); completed suicide risk rises with comorbid depression and substance use.[4]
- Risk factors include childhood adversity (both excessive praise without limits and emotional neglect or harsh criticism), insecure , and a heritable temperament marked by high reward sensitivity and low distress tolerance.[3,5]
The pathophysiology of NPD is best framed as a heritable temperament shaped by adverse developmental experiences, with downstream effects on social-cognitive circuits that process empathy, self-referential thought, and reward. No single neurobiological lesion accounts for the disorder.[3,5]
Genetics and temperament
- Twin studies estimate heritability for narcissistic traits at roughly 0.45-0.80, with grandiose and vulnerable dimensions showing partly independent genetic loading.[5]
- Temperamental contributors include high novelty seeking, low harm avoidance in grandiose presentations, and high neuroticism in vulnerable presentations.[3,5]
Neurobiology
- Functional imaging studies report reduced activation in the anterior and decreased gray matter in the left anterior insula in patients with NPD during empathy tasks, consistent with deficits in affective empathy.[6]
- Abnormalities in medial and the have been described, mirroring the disorder's prominent self-referential processing.[6]
- No reliable peripheral biomarker exists; imaging findings are group-level and not diagnostic.[6]
Developmental and environmental factors
- Psychodynamic models (Kernberg, Kohut) describe NPD as a failure of integration of grandiose and devalued self-representations, with the grandiose self defending against underlying shame and emptiness.[3,7]
- Both excessive idealization without limit-setting and chronic devaluation or neglect during childhood are associated with later narcissistic pathology.[3,5]
- Attachment research links NPD with dismissing (grandiose) and preoccupied or fearful (vulnerable) attachment styles.[5]
DSM-5-TR places NPD in the Cluster B personality disorders, defined by a pervasive pattern of grandiosity (in fantasy or behavior), need for admiration, and lack of empathy, beginning by early adulthood and present across contexts, with five or more of nine criteria required.[3]
DSM-5-TR criteria (paraphrased)
- Grandiose sense of self-importance, with exaggeration of achievements and talents and an expectation to be recognized as superior without commensurate accomplishments.[3]
- Preoccupation with fantasies of unlimited success, power, brilliance, beauty, or ideal love.[3]
- Belief that one is special and unique and can only be understood by, or should associate with, other high-status people or institutions.[3]
- Need for excessive admiration.[3]
- Sense of entitlement, with unreasonable expectations of favorable treatment or automatic compliance with one's expectations.[3]
- Interpersonally exploitative behavior, taking advantage of others to achieve one's own ends.[3]
- Lack of empathy: unwillingness to recognize or identify with the feelings and needs of others.[3]
- Often envious of others or believes others are envious of oneself.[3]
- Arrogant, haughty behaviors or attitudes.[3]
General personality-disorder requirements
- Pattern is pervasive, inflexible, and stable across time and situations, with onset by early adulthood.[3]
- Causes clinically significant distress or impairment in social, occupational, or other functioning.[3]
- Not better explained by another mental disorder, substance use, or medical condition.[3]
NPD presents along a spectrum from overt grandiosity to covert vulnerability, often shifting within the same patient over time and across contexts.[7,9] Recognition matters because covert presentations are easily missed and overt presentations frequently masquerade as confidence or high achievement.
Overt (grandiose) presentation
- Visible self-importance, dismissive or condescending interpersonal style, and overt entitlement.[7,9]
- Often functions well occupationally until a status threat (demotion, public criticism, infidelity) precipitates collapse.[9]
- May present to psychiatry only under external pressure (court mandate, spouse ultimatum, occupational referral).[9]
Covert (vulnerable) presentation
- Hypersensitivity to criticism, shame-proneness, and chronic emptiness, often with a self-effacing surface concealing grandiose fantasies.[7,9]
- More likely to present with depression, anxiety, somatic complaints, or suicidality after narcissistic injury.[9]
- Frequently mistaken for major depressive disorder, social anxiety disorder, or on first encounter.[9]
Cross-cutting features
- Affective dysregulation centered on shame, rage, and envy rather than the abandonment-driven dysregulation of .[7]
- Impaired empathy is more often a cognitive-emotional disconnect (can recognize but not feel with others) than a global empathy deficit.[6-7]
- Interpersonal relationships are typically transactional, with rapid idealization followed by devaluation.[7]
Covert narcissism often presents as with shame-driven suicidality; screen for personality structure before iterating antidepressants.[9]
The differential is broad because grandiosity, entitlement, and impaired empathy appear in mood, psychotic, substance-induced, and other personality disorders. Longitudinal pattern and pervasiveness across contexts distinguish NPD from episodic or substance-related grandiosity.[3,7]
Other personality disorders
- : shares exploitativeness and lack of empathy, but is defined by disregard for and violation of others' rights, before 15, and overt aggression and criminality more than admiration-seeking.[3]
- Borderline personality disorder: affective instability is abandonment-driven rather than shame-driven; identity disturbance is global rather than grandiose; self-harm and chronic suicidality are more prominent.[3,7]
- : attention-seeking is sexualized and emotional rather than admiration-seeking and superiority-based.[3]
- : perfectionism and rigidity without the entitlement, exploitativeness, or grandiose fantasy of NPD.[3]
Mood and psychotic disorders
- Bipolar I or II disorder, manic or hypomanic episode: grandiosity is episodic, accompanied by decreased need for sleep, pressured speech, and goal-directed activity, with a return to baseline between episodes.[3]
- Major depressive disorder: vulnerable narcissism may mimic MDD; the diagnosis of NPD requires the pervasive pattern across contexts and time independent of mood episodes.[3,9]
- or , grandiose type: grandiosity reaches delusional intensity and is accompanied by other psychotic features; NPD grandiosity is non-delusional and reality-tested under pressure.[3]
Substance-induced and medical mimics
- Stimulant intoxication (cocaine, methamphetamine, prescribed psychostimulants at high dose) can produce transient grandiosity; resolves with abstinence.[3]
- Frontal lobe lesions, (behavioral variant), and traumatic brain injury can produce disinhibition, grandiosity, and impaired empathy; onset is later in life and cognitive testing and neuroimaging are abnormal.[10]
- Hyperthyroidism, Cushing , and steroid-induced mood changes can mimic mood and personality features; screen with TSH and history of exogenous steroid use when presentation is atypical.[10]
| Feature | NPD | Antisocial PD | Borderline PD | Bipolar I (manic) |
|---|---|---|---|---|
| Core driver | Admiration, status | Disregard for others' rights | Fear of abandonment | Mood episode |
| Grandiosity | Persistent, pervasive | Variable, instrumental | Episodic, mood-linked | Episodic, with |
| Empathy | Impaired, especially affective | Globally impaired | Variable, can be intense | Intact between episodes |
| Course | Stable from early adulthood | Stable from adolescence | Stable from early adulthood | Episodic |
| First-line management | Psychotherapy | Psychotherapy; limited pharmacotherapy | Psychotherapy (DBT, MBT, TFP) | , antipsychotic |
Assessment is built on a longitudinal history across multiple domains and informants, not a single cross-sectional interview. Patients with NPD often present in crisis, and the personality structure becomes visible only as the crisis resolves.[7,9]
Interview approach
- Establish a non-confrontational stance; direct challenge to grandiosity early in treatment provokes shame and dropout.[11]
- Track shifts between idealization and devaluation of the clinician, prior providers, and significant others as diagnostic data.[7]
- Ask explicitly about responses to criticism, perceived slights, and status loss; these probe the core vulnerability.[9]
History to obtain
- Longitudinal pattern of relationships, work, and self-image across contexts and time (required for any personality-disorder diagnosis).[3]
- Trauma history, childhood adversity, attachment patterns, and parental modeling.[3,5]
- Substance use, suicide history (especially after narcissistic injury), and prior episodes of depression or rage.[1,4]
- Collateral history from family or partners when available and consented; self-report alone underestimates interpersonal pathology.[9]
Validated rating scales
- (PNI): self-report measure capturing grandiose and vulnerable dimensions.[15]
- (NPI): widely used in research; better suited to trait narcissism than clinical NPD.[15]
- (SCID-5-PD): semi-structured clinical interview covering all personality disorders.[16]
- (PID-5): trait-based instrument aligned with the Section III alternative model.[3]
Labs and imaging
- No laboratory or imaging study confirms NPD; obtain only what is needed to rule out medical mimics suggested by history.[10]
- When grandiosity is new-onset in midlife or later, consider TSH, basic metabolic panel, urine toxicology, and neurologic evaluation including neuroimaging for frontotemporal pathology.[10]
- Do NOT order routine neuroimaging in a young adult with a longstanding pattern consistent with NPD.[10]
Psychotherapy is the foundation of NPD treatment; no medication is FDA-approved for the disorder, and pharmacotherapy targets comorbid conditions and specific symptom domains.[11] Evidence is limited to small trials, naturalistic studies, and expert consensus, so wording across this section reflects that uncertainty.
Pharmacotherapy
- No medication is FDA-approved for NPD; some experts recommend pharmacotherapy targeting comorbid major depressive disorder, anxiety disorders, or impulsive aggression, though high-quality evidence is lacking.[11,17]
- For comorbid major depressive disorder, such as sertraline 50 mg PO QD or escitalopram 10 mg PO QD are commonly used, with dosing and monitoring as for primary MDD.[12,17]
- (, valproate) and have been used off-label for affective instability and impulsive aggression in Cluster B disorders; evidence for NPD specifically is limited.[17]
- Avoid as standing therapy given high comorbidity with substance use disorders.[1,17]
Psychotherapy
- Limited evidence suggests that structured, long-term psychotherapies developed for borderline and other severe personality disorders can be adapted for NPD, with high attrition and slow change as the rule.[11,18]
- (TFP): manualized psychodynamic treatment developed by Kernberg's group; targets integration of split self- and object-representations; evidence base strongest in borderline personality disorder with extension to narcissistic patients.[18]
- (MBT): targets capacity to understand mental states in self and others; small studies and case series suggest benefit in narcissistic patients.[18]
- : integrates cognitive, behavioral, and experiential techniques to address early maladaptive schemas; limited NPD-specific RCT evidence.[19]
- Supportive psychotherapy and cognitive-behavioral approaches focused on specific problems (anger management, interpersonal effectiveness) are common in practice; evidence quality is low.[11]
- Maintaining the therapeutic alliance through narcissistic injury, ruptures, and devaluation is the central technical challenge; ruptures predict dropout and are themselves clinical material.[11,14,18]
Neuromodulation
- No neuromodulation modality (, , VNS) is indicated for NPD itself.[11]
- ECT and rTMS retain their usual indications for comorbid severe or treatment-resistant depression; personality pathology does not preclude their use but may predict poorer durability of response.[11]
Adjunctive
- Treat comorbid substance use disorders concurrently; untreated substance use undermines all psychotherapy.[1,11]
- Couples and family interventions can address relational damage and reduce drop-out by stabilizing the patient's environment.[11]
- Group therapy is used cautiously; some patients tolerate it well, while others use the group to enact grandiosity or sustain narcissistic injury.[11]
- Address occupational and forensic stressors (job loss, divorce, legal involvement) directly, as these are common precipitants of crisis and dropout.[9,11]
| Intervention | Evidence base/Comparator | Benefits | Harms | Certainty | Notes |
|---|---|---|---|---|---|
| Transference-focused psychotherapy | Small RCTs and case series, mostly in BPD with NPD subgroups[18] | Improved reflective functioning, reduced attrition in some studies | Long duration, demanding for therapist and patient | low | Manualized; trained therapists scarce |
| Mentalization-based treatment | Case series and small trials extrapolated from BPD evidence[18] | Improved mentalizing, interpersonal function | Limited NPD-specific data | low | Group plus individual format |
| Schema therapy | Small trials in mixed personality disorder samples[19] | Reduction in maladaptive schemas, symptom improvement | Limited NPD-specific RCT data | low | Integrates cognitive and experiential work |
| Supportive/CBT psychotherapy | Naturalistic studies and expert opinion[11] | Pragmatic, widely available; useful for circumscribed problems | Unlikely to alter core personality structure | very_low | Often the realistic option in routine care |
| SSRIs for comorbid MDD | Extrapolated from MDD RCTs; no NPD-specific RCTs[17] | Reduces depressive and anxiety symptoms | Sexual dysfunction, GI upset, | moderate (for MDD); very_low (for NPD per se) | Treats comorbidity, not NPD |
| Mood stabilizers/antipsychotics for affective instability | Small Cluster B trials, mostly BPD[17] | May reduce impulsive aggression | Metabolic, neurologic, renal effects | very_low | Use targeted to specific symptoms |
Harms in NPD arise more from the natural history of the disorder and from iatrogenic prescribing than from any single treatment. The evidence base is thin, and most recommendations rest on expert consensus and extrapolation from borderline personality disorder.[11,18]
Common harms of management
- Polypharmacy when antidepressants, antipsychotics, mood stabilizers, and benzodiazepines accumulate across crises without clear targets.[17]
- Iatrogenic dependence on benzodiazepines, especially given comorbid substance use disorders.[1,17]
- Therapist burnout and boundary lapses in long-term psychotherapy without supervision and structured frameworks.[11]
Serious or rare harms
- Suicide after narcissistic injury, particularly in patients with comorbid depression, substance use, or recent humiliation; risk may be acute and short-window.[4]
- Aggression toward intimate partners or perceived rivals, especially in patients with antisocial features.[1]
- Forensic involvement (workplace complaints, intimate partner violence, financial fraud) with secondary mental-health consequences.[1,7]
Limitations of the evidence base
- Most psychotherapy trials enroll mixed personality disorder samples dominated by borderline personality disorder; NPD-specific effect sizes are imprecise.[11,18]
- Short follow-up in available trials underestimates relapse and long-term functional outcome.[11]
- Publication bias toward positive psychotherapy trials and minimal industry interest in NPD pharmacotherapy leave both literatures underpowered.[11,17]
- Diagnostic instability across overt and covert presentations and across DSM-5-TR and ICD-11 frameworks complicates pooling of data.[3,8]
NPD has the same core features across populations, but presentation, comorbidity, and treatment access vary. Cultural framing of self-presentation deserves explicit attention before applying the diagnosis cross-culturally.[3,7]
Pediatric and adolescent
- Personality disorders are not typically diagnosed before age 18; narcissistic traits in adolescence may reflect normative developmental processes.[3]
- Persistent, pervasive, and impairing patterns from mid-adolescence warrant treatment of the presenting symptoms (depression, conduct, substance use) and longitudinal reassessment.[3]
Geriatric
- New-onset grandiosity or behavioral disinhibition in late life should prompt evaluation for frontotemporal dementia, stroke, or other neurologic disease rather than a primary personality disorder diagnosis.[10]
- Older adults with longstanding NPD may decompensate around retirement, illness, or loss of status, with depression and suicide risk.[4,9]
Perinatal
- Pregnancy and postpartum can intensify narcissistic injury around bodily change, role shift, and infant demands; screen for postpartum depression and impaired bonding.[20]
- Pharmacologic decisions follow standard perinatal psychiatry: SSRIs are generally compatible with pregnancy and lactation when indicated for comorbid depression or anxiety.[17]
Comorbid medical illness and substance use
- Comorbid substance use disorders are common and worsen suicide risk and treatment dropout; integrated treatment is preferred.[1,11]
- Adherence to medical regimens may be undermined by entitlement and devaluation of clinicians; engagement strategies parallel those used in .[11]
Cultural considerations
NPD is chronic but not static. Some patients improve with maturation and life experience, while others worsen around predictable crises.[7,9] Functional outcome varies more by comorbidity and social environment than by narcissism severity alone.
Natural history
- Cluster B traits, including narcissistic traits, tend to attenuate with age in cross-sectional data; this does not mean every patient improves.[1-2]
- Functional outcomes are best when occupational success is preserved and worst after status loss, divorce, or legal involvement.[9]
Response and relapse
- Limited evidence suggests that structured long-term psychotherapies produce slow, partial improvement in interpersonal functioning and comorbid symptoms.[11,18]
- High attrition is the rule; dropout rates in personality-disorder trials commonly exceed 30-50%.[18]
- Comorbid major depressive disorder generally responds to standard treatment, though residual interpersonal impairment persists.[17]
Suicide and mortality
Acute presentations cluster around narcissistic injury: job loss, public humiliation, divorce, or perceived betrayal. Risk is real, often time-limited, and easily underestimated when the patient presents with apparent composure.[4,9]
Hospitalization criteria
- Imminent risk of suicide or homicide, particularly after acute narcissistic injury, warrants emergency assessment and consideration of admission.[4]
- Inability to maintain safety in the outpatient setting, severe comorbid depression, or acute psychotic features.[4]
- Brief admissions to manage acute risk are preferred; prolonged inpatient stays risk regression and conflict with staff.[11]
Suicide risk markers
- Recent humiliation or status loss within days to weeks of presentation.[4,9]
- Comorbid major depressive disorder, substance use, or prior attempt.[4]
- Access to lethal means, especially firearms in high-conflict separations.[4]
- Concealed planning; patients may underreport intent to preserve self-image, so collateral information is valuable.[4,9]
Agitation and aggression
- De-escalation prioritizes face-saving and limited audience; public confrontation worsens behavior.[11]
- Treat acute agitation per standard emergency-psychiatry approaches, with attention to comorbid intoxication.[21]
- Document threats toward identifiable third parties and apply jurisdictional duty-to-warn or duty-to-protect requirements.[22]
NPD sits at the contested boundary between categorical and dimensional models of personality, and between trait narcissism in the general population and a clinical disorder. Several debates have direct clinical implications.[3,8]
Categorical versus dimensional classification
- DSM-5-TR retains the categorical NPD diagnosis in Section II and offers the AMPD in Section III; ICD-11 has moved fully to a dimensional model.[3,8]
- Researchers disagree on whether the dimensional model better captures clinical reality or whether it loses information clinicians use for treatment planning.[3,8]
Grandiose versus vulnerable phenotypes
- The grandiose-vulnerable distinction is well replicated in trait studies; whether they represent two disorders, two presentations of one disorder, or shifting states in the same patient remains debated.[7,9]
- DSM-5-TR criteria emphasize the grandiose presentation; covert narcissism risks under-diagnosis at the bedside.[9]
Evidence base for treatment
- No medication is approved for NPD, and psychotherapy trials are small and heterogeneous; routine practice depends heavily on expert consensus and extrapolation from borderline personality disorder.[11,17-18]
- Some experts argue that long-term, manualized psychodynamic treatments should be the standard of care; others emphasize pragmatic, problem-focused work given access constraints.[11,18]
Diagnosis in non-clinical settings
- NPD requires a pervasive pattern of grandiosity, need for admiration, and lack of empathy with at least five of nine DSM-5-TR criteria beginning by early adulthood.[1]
- Lifetime prevalence is approximately 6% in US community samples, higher in men than women.[2]
- Narcissistic injury, defined as the response to perceived failure or humiliation, is the most common trigger for suicidal crisis in NPD.[5,15]
- Covert (vulnerable) narcissism presents with shame, hypersensitivity, and depression, and is more likely to seek treatment than the grandiose subtype.[8]
- The Pathological Narcissism Inventory captures both grandiose and vulnerable dimensions; the Narcissistic Personality Inventory captures grandiose traits primarily.[9-10]
- No medication is FDA-approved for NPD; pharmacotherapy targets comorbid depression, anxiety, or impulsive aggression rather than the personality structure.[8,17]
- Transference-focused psychotherapy, mentalization-based treatment, and schema therapy are the psychotherapies with the most direct evidence in narcissistic and borderline pathology.[8,13,18]
- Antisocial personality disorder shares grandiosity and lack of empathy but is distinguished by criminal conduct, deceitfulness, and disregard for the rights of others.[1]
- Bipolar disorder mania can mimic grandiosity but is episodic with mood elevation, decreased need for sleep, and pressured speech; NPD traits are pervasive and stable.[1]
- ICD-11 has replaced categorical personality disorder diagnoses with a dimensional severity-plus-trait model retaining "" only as a qualifier.[6,8]
- Comorbidity with major depressive disorder, substance use disorders, and other Cluster B personality disorders is the rule rather than the exception.[2-3]
- The DSM-5 Alternative Model for Personality Disorders defines NPD by impairment in self and interpersonal functioning plus the traits of grandiosity and attention-seeking.[1,8]
- Suicide attempts in NPD are often high-lethality and follow status loss or public humiliation rather than chronic suicidal ideation.[4,15]
- Treatment retention is the central challenge: dropout rates exceed 50% in many cohorts, and engagement strategies are as important as the specific therapy modality.[8,18]
No external funding. No conflicts of interest declared. Peer-review status: pending.
- 1.TextbookAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text rev. Washington, DC: American Psychiatric Association Publishing; 2022.
- 2.Stinson FS, Dawson DA, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV narcissistic personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2008;69(7):1033-1045. doi:10.4088/jcp.v69n0701. PMID: 18557663.PMID: 18557663doi:10.4088/jcp.v69n0701
- 3.Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010;24(4):412-426. doi:10.1521/pedi.2010.24.4.412. PMID: 20695803.PMID: 20695803doi:10.1521/pedi.2010.24.4.412
- 4.Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000;41(6):416-425. doi:10.1053/comp.2000.16560. PMID: 11086146.PMID: 11086146doi:10.1053/comp.2000.16560
- 5.TextbookRonningstam E. Identifying and Understanding the Narcissistic Personality. New York: Oxford University Press; 2005.
- 6.TextbookWorld Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva: World Health Organization; 2019.
- 7.TextbookSadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock's Synopsis of Psychiatry. 12th ed. Philadelphia: Wolters Kluwer; 2022.
- 8.Caligor E, Levy KN, Yeomans FE. Narcissistic personality disorder: diagnostic and clinical challenges. Am J Psychiatry. 2015;172(5):415-422. doi:10.1176/appi.ajp.2014.14060723. PMID: 25930131.PMID: 25930131doi:10.1176/appi.ajp.2014.14060723
- 9.Pincus AL, Ansell EB, Pimentel CA, Cain NM, Wright AG, Levy KN. Initial construction and validation of the Pathological Narcissism Inventory. Psychol Assess. 2009;21(3):365-379. doi:10.1037/a0016530. PMID: 19719348.PMID: 19719348doi:10.1037/a0016530
- 10.Miller JD, Hoffman BJ, Gaughan ET, Gentile B, Maples J, Campbell WK. Grandiose and vulnerable narcissism: a nomological network analysis. J Pers. 2011;79(5):1013-1042. doi:10.1111/j.1467-6494.2010.00711.x. PMID: 21204843.PMID: 21204843doi:10.1111/j.1467-6494.2010.00711.x
- 11.Raskin R, Terry H. A principal-components analysis of the Narcissistic Personality Inventory and further evidence of its construct validity. J Pers Soc Psychol. 1988;54(5):890-902. doi:10.1037/0022-3514.54.5.890. PMID: 3379585.PMID: 3379585doi:10.1037/0022-3514.54.5.890
- 12.TextbookStahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge: Cambridge University Press; 2021.
- 13.Bateman A, Fonagy P. Mentalization-based treatment. Psychoanal Inq. 2013;33(6):595-613. doi:10.1080/07351690.2013.835170.doi:10.1080/07351690.2013.835170.
- 14.Diener MJ, Monroe JM. The relationship between adult attachment style and therapeutic alliance in individual psychotherapy: a meta-analytic review. Psychotherapy (Chic). 2011;48(3):237-248. doi:10.1037/a0022425. PMID: 21604902.PMID: 21604902doi:10.1037/a0022425
- 15.Links PS, Gould B, Ratnayake R. Assessing suicidal youth with antisocial, borderline, or narcissistic personality disorder. Can J Psychiatry. 2003;48(5):301-310. doi:10.1177/070674370304800505. PMID: 12866335.PMID: 12866335doi:10.1177/070674370304800505
- 16.GuidelineNational Institute for Health and Care Excellence. Borderline Personality Disorder: Recognition and Management. Clinical Guideline CG78. London: NICE; 2009.
- 17.TextbookSchatzberg AF, DeBattista C. Manual of Clinical Psychopharmacology. 9th ed. Washington, DC: American Psychiatric Association Publishing; 2019.
- 18.Paris J. Personality disorders over time: implications for psychotherapy. Am J Psychother. 2004;58(4):420-429. doi:10.1176/appi.psychotherapy.2004.58.4.420. PMID: 15692211.PMID: 15692211doi:10.1176/appi.psychotherapy.2004.58.4.420
- 19.TextbookHales RE, Yudofsky SC, Roberts LW. The American Psychiatric Publishing Textbook of Psychiatry. 7th ed. Washington, DC: American Psychiatric Association Publishing; 2019.
- 20.Expert opinionACOG Committee Opinion No. 757: Screening for Perinatal Depression. Obstet Gynecol. 2018;132(5):e208-e212. doi:10.1097/AOG.0000000000002927. PMID: 30629567.PMID: 30629567doi:10.1097/AOG.0000000000002927
- 21.GuidelineWilson MP, Pepper D, Currier GW, Holloman GH Jr, Feifel D. The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. West J Emerg Med. 2012;13(1):26-34. doi:10.5811/westjem.2011.9.6866. PMID: 22461918.PMID: 22461918doi:10.5811/westjem.2011.9.6866
- 22.Tarasoff v. Regents of the University of California, 17 Cal. 3d 425, 551 P.2d 334, 131 Cal. Rptr. 14 (Cal. 1976).
- 23.American Psychiatric Association. The Principles of Medical Ethics With Annotations Especially Applicable to Psychiatry. 2013 ed. Washington, DC: American Psychiatric Association; 2013. Section 7.3.
More on these topics
Obsessive-Compulsive Personality Disorder (OCPD): Diagnosis, Differential, and Evidence-Based Management
A clinical reference on OCPD covering DSM-5-TR criteria, differentiation from OCD, assessment, and evidence-based treatment.
Obsessive-Compulsive Personality DisorderPersonality DisordersDependent Personality Disorder: Diagnosis, Differential, and Management
Evidence-based overview of dependent personality disorder for clinicians: DSM-5-TR criteria, differential diagnosis, assessment, and psychotherapy-first treatment.
Dependent Personality DisorderPersonality DisordersAvoidant Personality Disorder: Diagnosis, Differential, and Evidence-Based Management
A clinical reference on avoidant personality disorder covering DSM-5-TR diagnosis, differentiation from social anxiety disorder, and evidence-based treatment.
Avoidant Personality DisorderPersonality DisordersHistrionic Personality Disorder: Clinical Features, Diagnosis, and Management
Clinical reference on histrionic personality disorder covering DSM-5-TR criteria, differential diagnosis, evidence-based psychotherapy, and exam-relevant pearls.
Histrionic Personality DisorderPersonality DisordersBorderline Personality Disorder: Diagnosis, Evidence-Based Treatment, and Clinical Management
A clinical reference on borderline personality disorder covering DSM-5-TR diagnosis, differential, evidence-based psychotherapies, and pharmacologic adjuncts.
Borderline Personality DisorderPersonality DisordersAntisocial Personality Disorder: Diagnosis, Assessment, and Management
Clinical reference on antisocial personality disorder covering DSM-5-TR criteria, differential diagnosis, evidence-based treatment, and forensic considerations.
Antisocial Personality DisorderPersonality DisordersSchizotypal Personality Disorder: Diagnosis, Differential, and Management
Clinical overview of schizotypal personality disorder, covering DSM-5-TR criteria, schizophrenia-spectrum biology, differential, and evidence-based management.
Schizotypal Personality DisorderPersonality DisordersSchizoid Personality Disorder: Diagnosis, Differential, and Management
A clinical review of schizoid personality disorder: DSM-5-TR criteria, differential diagnosis, assessment, and evidence-based management.
Schizoid Personality DisorderPersonality Disorders